GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 701 - 725 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 24 mild
G14988WV
385
IgG Patient 2 15 mild
G14988WV
162
IgG Patient 2 24 mild
G14988WV
164
IgM Patient 2 15 mild
G14988WV
203
IgM Patient 2 24 mild
G14988WV
233
IgA Patient 2 3 mild
G14988WV
371
IgG Patient 2 3 mild
G14988WV
181
IgM Patient 2 3 mild
G14988WV
255
IgA Patient 3 -180 mild
G14988WV
279
IgA Patient 3 11 mild
G14988WV
450
IgG Patient 3 -180 mild
G14988WV
48
IgG Patient 3 11 mild
G14988WV
115
IgM Patient 3 -180 mild
G14988WV
87
IgA Patient 3 4 mild
G14988WV
527
IgG Patient 3 4 mild
G14988WV
120
IgM Patient 3 11 mild
G14988WV
372
IgM Patient 3 4 mild
G14988WV
423
IgA Patient 4 12 mild
G14988WV
621
IgG Patient 4 12 mild
G14988WV
253
IgM Patient 4 12 mild
G14988WV
808
IgA Patient 1 10 moderate
G15209MJ
406
IgA Patient 1 22 moderate
G15209MJ
426
IgA Patient 1 6 moderate
G15209MJ
362
IgG Patient 1 10 moderate
G15209MJ
25
IgG Patient 1 22 moderate
G15209MJ
32

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024